3D Cell Culture Market Size & Share 2023 to 2032

Market Size by Type (Scaffold-based 3D Cell Cultures, Scaffold-free 3D Cell Cultures, Bioreactors, Microfluidic 3D Cell Culture) by Application (Cancer, Stem Cell Research, Drug Discovery & Toxicology Testing), by End Use & Forecast.
Report ID: GMI5602
   |
Published Date: May 2023
 | 
Report Format: PDF

Download Free PDF

3D Cell Culture Market Size

3D Cell Culture Market size exceeded more than USD 1.5 billion in 2022 and is projected to witness 14.3% CAGR during 2023-2032. Rising preference for efficient and affordable drug discovery methods to drive industry expansion.
 

3D Cell Culture Market

The surging emphasis on developing alternatives to animal testing will influence the expansion for 3D cell cultures. In recent years, most industries are working on the development of new platforms, such as innovative human 3D tissue-engineered models for replacing animal and flask cell-culture models. The increasing usage of organs-on-a-chip (OoCs) as an alternative candidate for drug screening and cell experiments will also anchor the market growth.|
 

The escalating costs associated with cell biology research may act as a significant restraint for the 3D cell culture market progress. This is mainly due to the tremendous inefficiencies incurred during the R&D activities. It has been estimated that scientists in the U.S. spend $28 billion per year on basic biomedical research that is not repeated successfully. The growing costs of biology lab equipment will also limit the rise for 3D cell cultures.
 

3D Cell Culture Market Analysis

Global 3D Cell Culture Market, By Type, 2021 - 2032 (USD Million)

3D cell culture market from Scaffold-based segment will exceed USD 3 billion by 2032. The expansion can be attributed to the increasing dominance of scaffolds in cell therapy and drug discovery applications. The growing burden of various chronic conditions, including cardiovascular diseases and cancer will further contribute to the adoption of scaffold-based 3D cell cultures.
 

Global 3D Cell Culture Market Share, By Application, 2022

3D cell culture market from the cancer application segment is likely hit USD 2.3 billion by 2032. 3D systems are increasingly deployed in cancer research as they facilitate efficacy testing, safety, and fundamental research. 3D cell culture models help in replicating the natural tumor architecture to provide an external proliferating zone, as well as nutrient and progression factor distribution. Increasing application in therapeutic fields, mainly in applications involving precision medicine will fuel to the market statistics.
 

North America 3D Cell Culture Market, 2022 - 2032 (USD Million)

North America registered 46.5% of the 3D cell culture market share in 2022 on account of the rising number of universities and research organisations in the region. The growing government initiatives and funding for the development of advanced 3D culture models will also bolster the regional business scenario. For instance, in March 2023, ALS Society of Canada (ALS Canada) joined forces with Brain Canada for investing $1.4 million to support 9 projects on cutting-edge discoveries as well as treatments for amyotrophic lateral sclerosis (ALS).
 

3D Cell Culture Market Share

Some of the prominent 3D cell culture industry players include :

  • CN Bio Innovations
  • Corning Incorporated
  • BiomimX SRL
  • Hurel Corporation
  • Merck KGaA
  • InSphero AG,
  • Lonza AG
  • MIMETAS BV
  • Nortis Inc.
  • Promocell GmbH
  • Sartorius AG
  • Becton
  • Dickinson 
  • Company
  • Thermo Fisher Scientific Inc.
     

3D Cell Culture Industry News

  • Avantor, in June 2022, partnered with GeminiBio, a leading chemical reagents and biological products supplier. The collaboration helped both the companies in meeting the rising demand for bioproduction workflow solutions.
     

The 3D cell culture market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments:

By Type

  • Scaffold-based 3D Cell Cultures
    • Hydrogels / ECM Analogs
    • Polymeric Scaffolds
    • Micro-patterned Surface Microplates
    • Nanofiber-based Scaffolds
  • Scaffold-free 3D Cell Cultures
    • Hanging Drop Microplates
    • Spheroid Microplates with ULA coating
    • Magnetic Levitation & 3D Bioprinting
    • 3D Petri Dishes
  • Bioreactors
  • Microfluidic 3D Cell Culture

By Application

  • Cancer
  • Stem Cell Research
  • Drug Discovery & Toxicology Testing
  • Tissue Engineering & Regenerative Medicine
  • Other Applications

By End-use

  • Biotechnology and Pharmaceutical Industries
  • Research Laboratories and Institutes
  • Hospitals and Diagnostic Centers
  • Other End Uses

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Poland
    • Switzerland
    • Netherlands
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Peru
    • Rest of Latin America
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Iraq
    • Israel
    • Rest of Middle East & Africa

 

Authors: Monali Tayade, Jignesh Rawal
3D Cell Culture Market Scope
  • 3D Cell Culture Market Size
  • 3D Cell Culture Market Trends
  • 3D Cell Culture Market Analysis
  • 3D Cell Culture Market Share

Report Content

Chapter 1   Methodology & Scope

1.1    Industry coverage

1.2    Market scope and definitions

1.3    Base estimates & working

1.3.1    Data collection

1.4    Forecast parameters

1.5    COVID-19 impact analysis at global level

1.6    Data validation

1.7    Data sources

1.7.1    Primary

1.7.2    Secondary

1.7.2.1   Paid sources

1.7.2.2   Public sources

Chapter 2   Executive Summary

2.1    3D cell culture industry 3600 synopsis, 2018 - 2032

2.1.1    Business trends

2.1.2    Type trends

2.1.3    Application trends

2.1.4    End-use trends

2.1.5    Regional trends

Chapter 3   3D Cell Culture Industry Insights

3.1    Industry segmentation

3.2    Industry landscape, 2018 – 2032

3.3    Industry impact forces

3.3.1    Growth drivers

3.3.1.1   Growing demand for better in vitro models

                                 3.3.1.2. Advancement in 3 D cell culture techniques

3.3.1.3   Increasing focus on developing alternatives to animal testing

3.3.2    Industry pitfalls & challenges

                                 3.3.2.1. Lack of consistency in 3 D cell culture products

3.3.2.2   High cost of cell biology research

3.4    Growth potential analysis

3.4.1    By type

3.4.2    By application

3.4.3    By end-use

3.5    COVID-19 impact analysis

3.6    Regulatory landscape

3.7    Advancement in 3D cell culture

3.8    Pricing analysis, by type, 2022

3.9    Porter’s analysis

3.10    PESTEL analysis

Chapter 4   Competitive Landscape, 2022

4.1    Introduction

4.2    Company market share analysis

4.3    Company matrix analysis, 2022

4.4    Strategy dashboard, 2022

4.5    Competitive analysis of major market players

4.6    Competitive positioning matrix

4.7    Strategic outlook matrix

Chapter 5   3D Cell Culture Market, By Type

5.1    Key type trends

5.2    Scaffold-based 3D cell cultures

5.2.1    Market estimates and forecast, 2018 - 2032 (USD Million)

5.2.2    Hydrogels / ECM analogs

5.2.2.1   Market estimates and forecast, 2018 - 2032 (USD Million)

5.2.3    Polymeric scaffolds

5.2.3.1   Market estimates and forecast, 2018 - 2032 (USD Million)

5.2.4    Micro-patterned surface microplates

5.2.4.1   Market estimates and forecast, 2018 - 2032 (USD Million)

5.2.5    Nanofiber-based scaffolds

5.2.5.1   Market estimates and forecast, 2018 - 2032 (USD Million)

5.3    Scaffold-free 3D cell cultures

5.3.1    Market estimates and forecast, 2018 - 2032 (USD Million)

5.3.2    Hanging drop microplates

5.3.2.1   Market estimates and forecast, 2018 - 2032 (USD Million)

5.3.3    Spheroid microplates with ULA coating

5.3.3.1   Market estimates and forecast, 2018 - 2032 (USD Million)

5.3.4    Magnetic levitation & 3D bioprinting

5.3.4.1   Market estimates and forecast, 2018 - 2032 (USD Million)

5.3.5    3D petri dishes

5.3.5.1   Market estimates and forecast, 2018 - 2032 (USD Million)

5.4    Bioreactors

5.4.1    Market estimates and forecast, 2018 - 2032 (USD Million)

5.5    Microfluidic 3D cell culture

5.5.1    Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 6   3D Cell Culture Market, By Application

6.1    Key application trends

6.2    Cancer

6.2.1    Market estimates and forecast, 2018 - 2032 (USD Million)

6.3    Stem cell research

6.3.1    Market estimates and forecast, 2018 - 2032 (USD Million)

6.4    Drug discovery & toxicology testing

6.4.1    Market estimates and forecast, 2018 - 2032 (USD Million)

6.5    Tissue engineering & regenerative medicine

6.5.1    Market estimates and forecast, 2018 - 2032 (USD Million)

6.6    Other applications

6.6.1    Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 7   3D Cell Culture Market, By End-use

7.1    Key end-use trends

7.2    Biotechnology and pharmaceutical industries

7.2.1    Market estimates and forecast, 2018 - 2032 (USD Million)

7.3    Research laboratories and institutes

7.3.1    Market estimates and forecast, 2018 - 2032 (USD Million)

7.4    Hospitals and diagnostic centers

7.4.1    Market estimates and forecast, 2018 - 2032 (USD Million)

7.5    Other end uses

7.5.1    Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 8   3D Cell Culture Market, By Region

8.1    Key regional trends

8.2    North America

8.2.1    U.S.

8.2.2    Canada

8.3    Europe

8.3.1    Germany

8.3.2    UK

8.3.3    France

8.3.4    Italy

8.3.5    Spain

8.3.6    Poland

8.3.7    Switzerland

8.3.8    Netherlands

8.3.9    Rest of Europe

8.4    Asia Pacific

8.4.1    China

8.4.2    Japan

8.4.3    India

8.4.4    Australia

8.4.5    South Korea

8.4.6    Indonesia

8.4.7    Thailand

8.4.8    Singapore

8.4.9    Malaysia

8.4.10    Rest of Asia Pacific

8.5    Latin America

8.5.1    Brazil

8.5.2    Mexico

8.5.3    Argentina

8.5.4    Colombia

8.5.5    Peru

8.5.6    Rest of Latin America

8.6    Middle East & Africa

8.6.1    South Africa

8.6.2    Saudi Arabia

8.6.3    UAE

8.6.4    Iraq

8.6.5    Israel

8.6.6    Rest of Middle East & Africa

Chapter 9   Company Profiles

9.1    BiomimX SRL

9.2    CN Bio Innovations Ltd.

9.3    Corning Incorporated

9.4    Hurel Corporation

9.5    InSphero AG

9.6    Lonza AG

9.7    Merck KGaA

9.8    MIMETAS BV

9.9    Nortis Inc.

9.10    Thermo Fisher Scientific

9.11    Sartorius AG

9.12    Promocell GmbH

9.13    Becton, Dickinson and Company

Don't see your key competitors?

The companies listed in this report are a curated selection - not the full competitive universe.

Our market revenue calculations use a bottom-up methodology that accounts for all players across all regions - including manufacturers, distributors, and specialists not individually profiled. The profiles section spotlights strategically significant players; it does not define the scope of our market sizing.

Your competitive landscape may also include

Regional or domestic-only leaders not in the global top tier
Distributors and channel partners who control market access
Emerging disruptors, startups, or adjacent-industry entrants
Niche players focused on a specific application or end-use

Free customization - up to 20% of report value

Need specific data? Request customization and get the insights tailored to your exact requirements.

Authors: Monali Tayade, Jignesh Rawal

For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at [email protected]

Explore Our Licensing Options:

Starting at: $2,450

Premium Report Details

Base Year: 2022

Companies Profiled: 13

Tables & Figures: 466

Countries covered: 29

Pages: 150

Download Free PDF